• ​​​​​​Baby Biome Study
• Integrating pharmacological modelling with conventional microbiology
• Modelling and cost effectiveness analysis to inform response to high levels of HIV drug resistance in sub-Saharan Africa, including deployment of new drug regimens (HIV Synthesis Model)